Evolution of clinical dimensions and safety in patients with major depressive disorder treated by esketamine: the French real-world ELLIPSE study

Neuroscience Applied 2026 Open access

Read full text

Authors: P.-M. Llorca, A. Sauvaget, E. Olié, Ludovic Samalin, P. Demaricourt, E. Gaudre-Wattinne, H. Lacour, J. Dupin, C. Wicart

DOI: 10.1016/j.nsa.2025.105943

Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Anxiety Depression Psychometrics Treatment Cognitive Processes Neurotransmitter Receptor Influence on Behavior